查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1869734

美国週边神经刺激设备市场规模、份额和趋势分析报告：按产品类型、模式、性别、应用、最终用途和细分市场预测（2025-2033 年）

U.S. Peripheral Nerve Stimulators Market Size, Share & Trends Analysis Report By Product Type (Systems, Wearables/Accessories), By Modality (Rechargeable, Non-rechargeable), By Connectivity, By Application, By End Use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 300 Pages | 商品交期: 2-10个工作天内

价格

市场规模与趋势：

据估计，2024年美国週边神经刺激设备市值为1.0514亿美元，预计2033年将达到2.5336亿美元。

预计从 2025 年到 2033 年，该产业将以 10.43% 的复合年增长率成长。美国週边神经刺激设备产业的主要驱动力是慢性疼痛疾病的日益普遍、对微创和标靶疼痛管理疗法的需求不断增长，以及向非鸦片类药物疗法的转变。

医疗专业人员和患者对週边神经刺激改善生活品质的有效性认识不断提高，推动了该技术的普及应用。植入式系统、穿戴式刺激器和先进的可编程性等技术进步进一步促进了市场成长。门诊手术中心的扩张、有利的报销政策以及人口老化带来的高手术量，都为市场的持续成长做出了贡献。

慢性疾病的日益普遍推动了美国週边神经刺激设备产业的成长，因为患有糖尿病、肥胖症、高血压、气喘和慢性疼痛等疾病的患者越来越需要有针对性的长期疼痛管理方案。週边神经刺激设备提供了一种微创治疗选择，可以缓解这些疾病引起的疼痛，从而改善患者的治疗效果和生活品质。

例如，正如健康系统追踪机构（Health System Tracker）在2025年4月指出的那样，美国的慢性病患病率高于其他国家，其中肥胖症和糖尿病的患病率是其他国家的两倍多，气喘率是其他国家的1.7倍，忧郁症的总体负担也更重。这些高盛行率不仅增加了对先进疼痛管理疗法的需求，也显示了对有效且经临床验证的周边神经刺激解决方案的迫切需求。根据泛美卫生组织（PAHO）2025年7月的报告，心血管疾病是导致死亡的主要原因（216万人死亡），其次是癌症（137万人死亡）、糖尿病（超过42万人死亡）和慢性呼吸系统疾病（超过41.6万人死亡）。自杀是15至29岁年轻人死亡的第四大原因，夺走了100,760人的生命。

目录

第一章调查方法和范围

第二章执行摘要

第三章美国週边神经刺激设备市场变数、趋势与范围

  • 市场体系展望
    • 补贴市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 美国週边神经刺激设备市场分析工具
    • 产业分析—波特五力分析
    • PESTEL 分析

第四章美国週边神经刺激设备市场：产品类型估算与趋势分析

  • 细分仪表板
  • 美国週边神经刺激设备市场产品类型差异分析
  • 美国週边神经刺激设备市场规模及趋势分析（按产品类型划分）（2021-2033 年）
  • 系统
  • 穿戴式装置/配件

第五章美国週边神经刺激设备市场：模式估算与趋势分析

  • 细分仪表板
  • 美国週边神经刺激设备市场趋势与波动分析
  • 美国週边神经刺激设备市场规模及趋势分析（按模式划分，2021-2033 年）
  • 可充电的
  • 不可充电

第六章美国週边神经刺激设备市场：连结性估算与趋势分析

  • 细分仪表板
  • 美国週边神经刺激设备市场连结性波动分析
  • 美国週边神经刺激设备市场规模及趋势分析（依接取方式划分，2021-2033 年）
  • 有线
  • 无线的

第七章美国週边神经刺激设备市场：应用预测与趋势分析

  • 细分仪表板
  • 美国週边神经刺激设备市场应用趋势分析
  • 美国週边神经刺激设备市场规模及趋势分析（依接取方式划分，2021-2033 年）
  • 糖尿病週边神经病变疼痛
  • 慢性肌肉骨骼疼痛
  • 复杂性局部疼痛症候群（CRPS）
  • 头痛和偏头痛
  • 其他的

第八章美国週边神经刺激设备市场：终端用途预测与趋势分析

  • 细分仪表板
  • 美国週边神经刺激设备市场最终用途变化分析
  • 美国週边神经刺激设备市场规模及趋势分析（按最终用途划分）（2021-2033 年）
  • 医院和诊所
  • 门诊手术中心（ASC）
  • 物理治疗/復健中心
  • 其他的

第九章 竞争情势

  • 市场参与企业分类
  • 主要企业简介
    • B. Braun Medical Inc.
    • Nalu Medical, Inc
    • Curonix LLC.
    • SPR
    • Vygon
    • AirLife
    • Neuspera Medical
    • Anesthesia Associates, Inc.
    • AVNS
    • Mercury Medical
    • Medtronic
    • Boston Scientific Corporation
    • Abbott
    • Bioventus
    • Checkpoint Surgical Inc.
    • Nervonik, Inc
  • 公司市占率分析，2024 年
  • 其他主要市场参与者名单
Product Code: GVR-4-68040-771-2

Market Size & Trends:

The U.S. peripheral nerve stimulators market size was estimated at USD 105.14 million in 2024 and is projected to reach USD 253.36 million by 2033, growing at a CAGR of 10.43% from 2025 to 2033. The U.S. peripheral nerve stimulators industry is primarily driven by the rising prevalence of chronic pain conditions and increasing demand for minimally invasive, targeted pain management therapies, and the growing shift toward non-opioid therapies.

Growing awareness among healthcare providers and patients about the effectiveness of peripheral nerve stimulation in improving quality of life is fueling adoption. Technological advancements, including implantable systems, wearable stimulators, and enhanced programmable features, further propel market growth. The expansion of outpatient and ambulatory surgery centers, favorable reimbursement policies, and an aging population with higher surgical volumes contribute to the sustained momentum of the market.

Rising prevalence of chronic diseases continues to drive growth in the U.S. peripheral nerve stimulators industry, as patients with conditions such as diabetes, obesity, hypertension, asthma, and chronic pain increasingly require targeted, long-term pain management solutions. Peripheral nerve stimulators offer minimally invasive options to alleviate pain associated with these illnesses, improving patient outcomes and quality of life.

For instance, in April 2025, Health System Tracker highlighted that the U.S. has a higher rate of chronic diseases compared to peer nations, with over twice as many people affected by obesity and diabetes, 1.7 times more with asthma, and an overall higher burden of depression. This elevated prevalence of chronic conditions not only increases demand for advanced pain management therapies but also underscores the growing need for effective, clinically proven peripheral nerve stimulation solutions. According to the Pan American Health Organization's (PAHO) report, in July 2025, cardiovascular diseases led with 2.16 million deaths, followed by cancer (1.37 million), diabetes (over 420,000), and chronic respiratory conditions (more than 416,000). Suicide, the fourth leading cause of death among youth aged 15-29, claimed 100,760 lives.

U.S. Peripheral Nerve Stimulators Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. peripheral nerve stimulators market report based on product type, modality, connectivity, application, and end use:

  • Product Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Systems
  • Implantable
  • Non-implantable
    • Handheld
    • Others
  • Wearables/Accessories
  • Modality Outlook (Revenue, USD Million, 2021 - 2033)
  • Rechargeable
  • Non-rechargeable
  • Connectivity Outlook (Revenue, USD Million, 2021 - 2033)
  • Wired
  • Wireless
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Diabetic Peripheral Neuropathy Pain
  • Chronic Musculoskeletal Pain
  • Complex Regional Pain Syndrome (CRPS)
  • Headache and Migraine Disorders
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals and Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Physiotherapy/Rehabilitation Centers
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product Type
    • 1.2.2. Modality
    • 1.2.3. Connectivity
    • 1.2.4. Application
    • 1.2.5. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
    • 1.5.5. Information Analysis
    • 1.5.6. Data Analysis Models
  • 1.6. Market Formulation & Data Visualization
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Peripheral Nerve Stimulators Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. High and rising prevalence of chronic pain
      • 3.2.1.2. Shift away from opioids toward non-opioid/interventional therapies
      • 3.2.1.3. Evidence and real-world adoption showing clinical benefit
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High device and procedure costs
      • 3.2.2.2. Technological limitations
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Outpatient centers and ambulatory surgery as key settings
      • 3.2.3.2. Aging population and comorbidities
    • 3.2.4. Market Challenges Analysis
      • 3.2.4.1. Device-related risks and complications
      • 3.2.4.2. Intense market competition
  • 3.3. U.S. Peripheral Nerve Stimulators Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. U.S. Peripheral Nerve Stimulators Market: Product Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Peripheral Nerve Stimulators Market Product Type Movement Analysis
  • 4.3. U.S. Peripheral Nerve Stimulators Market Size & Trend Analysis, by Product Type, 2021 to 2033 (USD Million)
  • 4.4. Systems
    • 4.4.1. Systems U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.1.1. Implantable U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 4.4.1.1.1. Handheld
        • 4.4.1.1.2. Others
      • 4.4.1.2. Non-implantable U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Wearables/Accessories
    • 4.5.1. Wearables/Accessories U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Peripheral Nerve Stimulators Market: Modality Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Peripheral Nerve Stimulators Market Modality Movement Analysis
  • 5.3. U.S. Peripheral Nerve Stimulators Market Size & Trend Analysis, by Modality, 2021 to 2033 (USD Million)
  • 5.4. Rechargeable
    • 5.4.1. Rechargeable U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Non-rechargeable
    • 5.5.1. Non-rechargeable U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Peripheral Nerve Stimulators Market: Connectivity Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Peripheral Nerve Stimulators Market Connectivity Movement Analysis
  • 6.3. U.S. Peripheral Nerve Stimulators Market Size & Trend Analysis, by Connectivity, 2021 to 2033 (USD Million)
  • 6.4. Wired
    • 6.4.1. Wired U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Wireless
    • 6.5.1. Wireless U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Peripheral Nerve Stimulators Market: Application Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Peripheral Nerve Stimulators Market Connectivity Movement Analysis
  • 7.3. U.S. Peripheral Nerve Stimulators Market Size & Trend Analysis, by Connectivity, 2021 to 2033 (USD Million)
  • 7.4. Diabetic Peripheral Neuropathy Pain
    • 7.4.1. Diabetic Peripheral Neuropathy Pain U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Chronic Musculoskeletal Pain
    • 7.5.1. Chronic Musculoskeletal Pain U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Complex Regional Pain Syndrome (CRPS)
    • 7.6.1. Complex Regional Pain Syndrome (CRPS) U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Headache and Migraine Disorders
    • 7.7.1. Headache and Migraine Disorders U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Others
    • 7.8.1. Others U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. U.S. Peripheral Nerve Stimulators Market: End-Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. U.S. Peripheral Nerve Stimulators Market End-Use Movement Analysis
  • 8.3. U.S. Peripheral Nerve Stimulators Market Size & Trend Analysis, by End-Use, 2021 to 2033 (USD Million)
  • 8.4. Hospitals and Clinics
    • 8.4.1. Hospitals and Clinics U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Ambulatory Surgical Centers (ASCs)
    • 8.5.1. Ambulatory Surgical Centers (ASCs) U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Physiotherapy/Rehabilitation Centers
    • 8.6.1. Physiotherapy/Rehabilitation Centers U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. Others
    • 8.7.1. Others U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Key Company Profiles
    • 9.2.1. B. Braun Medical Inc.
      • 9.2.1.1. Company Overview
      • 9.2.1.2. Financial Performance
      • 9.2.1.3. Modality Benchmarking
      • 9.2.1.4. Strategic Initiatives
    • 9.2.2. Nalu Medical, Inc
      • 9.2.2.1. Company Overview
      • 9.2.2.2. Financial Performance
      • 9.2.2.3. Modality Benchmarking
      • 9.2.2.4. Strategic Initiatives
    • 9.2.3. Curonix LLC.
      • 9.2.3.1. Company Overview
      • 9.2.3.2. Financial Performance
      • 9.2.3.3. Modality Benchmarking
      • 9.2.3.4. Strategic Initiatives
    • 9.2.4. SPR
      • 9.2.4.1. Company Overview
      • 9.2.4.2. Financial Performance
      • 9.2.4.3. Modality Benchmarking
      • 9.2.4.4. Strategic Initiatives
    • 9.2.5. Vygon
      • 9.2.5.1. Company Overview
      • 9.2.5.2. Financial Performance
      • 9.2.5.3. Modality Benchmarking
      • 9.2.5.4. Strategic Initiatives
    • 9.2.6. AirLife
      • 9.2.6.1. Company Overview
      • 9.2.6.2. Financial Performance
      • 9.2.6.3. Modality Benchmarking
      • 9.2.6.4. Strategic Initiatives
    • 9.2.7. Neuspera Medical
      • 9.2.7.1. Company Overview
      • 9.2.7.2. Financial Performance
      • 9.2.7.3. Modality Benchmarking
      • 9.2.7.4. Strategic Initiatives
    • 9.2.8. Anesthesia Associates, Inc.
      • 9.2.8.1. Company Overview
      • 9.2.8.2. Financial Performance
      • 9.2.8.3. Modality Benchmarking
      • 9.2.8.4. Strategic Initiatives
    • 9.2.9. AVNS
      • 9.2.9.1. Company Overview
      • 9.2.9.2. Financial Performance
      • 9.2.9.3. Modality Benchmarking
      • 9.2.9.4. Strategic Initiatives
    • 9.2.10. Mercury Medical
      • 9.2.10.1. Company Overview
      • 9.2.10.2. Financial Performance
      • 9.2.10.3. Modality Benchmarking
      • 9.2.10.4. Strategic Initiatives
    • 9.2.11. Medtronic
      • 9.2.11.1. Company Overview
      • 9.2.11.2. Financial Performance
      • 9.2.11.3. Modality Benchmarking
      • 9.2.11.4. Strategic Initiatives
    • 9.2.12. Boston Scientific Corporation
      • 9.2.12.1. Company Overview
      • 9.2.12.2. Financial Performance
      • 9.2.12.3. Modality Benchmarking
      • 9.2.12.4. Strategic Initiatives
    • 9.2.13. Abbott
      • 9.2.13.1. Company Overview
      • 9.2.13.2. Financial Performance
      • 9.2.13.3. Modality Benchmarking
      • 9.2.13.4. Strategic Initiatives
    • 9.2.14. Bioventus
      • 9.2.14.1. Company Overview
      • 9.2.14.2. Financial Performance
      • 9.2.14.3. Modality Benchmarking
      • 9.2.14.4. Strategic Initiatives
    • 9.2.15. Checkpoint Surgical Inc.
      • 9.2.15.1. Company Overview
      • 9.2.15.2. Financial Performance
      • 9.2.15.3. Modality Benchmarking
      • 9.2.15.4. Strategic Initiatives
    • 9.2.16. Nervonik, Inc
      • 9.2.16.1. Company Overview
      • 9.2.16.2. Financial Performance
      • 9.2.16.3. Modality Benchmarking
      • 9.2.16.4. Strategic Initiatives
  • 9.3. Company Market Share Analysis, 2024
  • 9.4. List of Other Key Market Players

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 U.S. Peripheral Nerve Stimulators Market, by Product Type, 2021 - 2033 (USD Million)
  • Table 4 U.S. Peripheral Nerve Stimulators Market, by Modality, 2021 - 2033 (USD Million)
  • Table 5 U.S. Peripheral Nerve Stimulators Market, by Connectivity, 2021 - 2033 (USD Million)
  • Table 6 U.S. Peripheral Nerve Stimulators Market, by Application, 2021 - 2033 (USD Million)
  • Table 7 U.S. Peripheral Nerve Stimulators Market, by End-Use, 2021 - 2033 (USD Million)
  • Table 8 Participant's Overview
  • Table 9 Financial Performance
  • Table 10 Modality Benchmarking
  • Table 11 Strategic Initiatives

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 U.S. Peripheral Nerve Stimulators Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 11 Porter's Five Forces Analysis
  • Fig. 12 Regional Marketplace: Key Takeaways
  • Fig. 13 U.S. Peripheral Nerve Stimulators Market, for Product Type, 2021 - 2033 (USD Million)
  • Fig. 14 U.S. Peripheral Nerve Stimulators Market, for Systems, 2021 - 2033 (USD Million)
  • Fig. 15 U.S. Peripheral Nerve Stimulators Market, for Implantable, 2021 - 2033 (USD Million)
  • Fig. 16 U.S. Peripheral Nerve Stimulators Market, for Non-Implantable, 2021 - 2033 (USD Million)
  • Fig. 17 U.S. Peripheral Nerve Stimulators Market, for Handheld, 2021 - 2033 (USD Million)
  • Fig. 18 U.S. Peripheral Nerve Stimulators Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 19 U.S. Peripheral Nerve Stimulators Market, for Wearables/Accessories, 2021 - 2033 (USD Million)
  • Fig. 20 U.S. Peripheral Nerve Stimulators Market, for Rechargeable, 2021 - 2033 (USD Million)
  • Fig. 21 U.S. Peripheral Nerve Stimulators Market, for Non-rechargeable, 2021 - 2033 (USD Million)
  • Fig. 22 U.S. Peripheral Nerve Stimulators Market, for Connectivity, 2021 - 2033 (USD Million)
  • Fig. 23 U.S. Peripheral Nerve Stimulators Market, for Wired, 2021 - 2033 (USD Million)
  • Fig. 24 U.S. Peripheral Nerve Stimulators Market, for Wireless, 2021 - 2033 (USD Million)
  • Fig. 25 U.S. Peripheral Nerve Stimulators Market, for Application, 2021 - 2033 (USD Million)
  • Fig. 26 U.S. Peripheral Nerve Stimulators Market, for Diabetic Peripheral Neuropathy Pain, 2021 - 2033 (USD Million)
  • Fig. 27 U.S. Peripheral Nerve Stimulators Market, for Chronic Musculoskeletal Pain, 2021 - 2033 (USD Million)
  • Fig. 28 U.S. Peripheral Nerve Stimulators Market, for Complex Regional Pain Syndrome (CRPS), 2021 - 2033 (USD Million)
  • Fig. 29 U.S. Peripheral Nerve Stimulators Market, for Headache and Migraine Disorders, 2021 - 2033 (USD Million)
  • Fig. 30 U.S. Peripheral Nerve Stimulators Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 31 U.S. Peripheral Nerve Stimulators Market, for End Use, 2021 - 2033 (USD Million)
  • Fig. 32 U.S. Peripheral Nerve Stimulators Market, for Hospitals and Clinics, 2021 - 2033 (USD Million)
  • Fig. 33 U.S. Peripheral Nerve Stimulators Market, for Ambulatory Surgical Centers (ASCs), 2021 - 2033 (USD Million)
  • Fig. 34 U.S. Peripheral Nerve Stimulators Market, for Physiotherapy/Rehabilitation Centers, 2021 - 2033 (USD Million)
  • Fig. 35 U.S. Peripheral Nerve Stimulators Market, for Others, 2021 - 2033 (USD Million)